APA (7th ed.) Citation

R, R., T, P., PK, D., S, S., SS, R., M, B., & N, B. (2026). ERK-mTOR crosstalk suppresses autophagy and upregulates proteasomal degradation pathway to confer chronic myeloid leukemia cells resistant to imatinib. Experimental hematology, 154, 105330. https://doi.org/10.1016/j.exphem.2025.105330

Chicago Style (17th ed.) Citation

R, Roy, Paul T, Das PK, Sinha S, Ray SS, Bhattacharyya M, and Biswas N. "ERK-mTOR Crosstalk Suppresses Autophagy and Upregulates Proteasomal Degradation Pathway to Confer Chronic Myeloid Leukemia Cells Resistant to Imatinib." Experimental Hematology 154 (2026): 105330. https://doi.org/10.1016/j.exphem.2025.105330.

MLA (9th ed.) Citation

R, Roy, et al. "ERK-mTOR Crosstalk Suppresses Autophagy and Upregulates Proteasomal Degradation Pathway to Confer Chronic Myeloid Leukemia Cells Resistant to Imatinib." Experimental Hematology, vol. 154, 2026, p. 105330, https://doi.org/10.1016/j.exphem.2025.105330.